Anti-CGRP and anti-CGRP receptor monoclonal antibodies as antimigraine agents. Potential differences in safety profile postulated on a pathophysiological basis
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Peptidomics approach to elucidate the proteolytic regulation of bioactive peptidesProceedings of the National Academy of Sciences, 2012
- Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonists in the Treatment of MigraineCNS Drugs, 2010
- Neurobiology of migraineNeuroscience, 2009
- Proinflammatory-Activated Trigeminal Satellite Cells Promote Neuronal Sensitization: Relevance for Migraine PathologyMolecular Pain, 2009
- Calcitonin Gene-Related Peptide Protects Against Hypertension-Induced Heart and Kidney DamageHypertension, 2005
- Calcitonin Gene-Related Peptide Is a Depressor in N G -Nitro- l -Arginine Methyl Ester-Induced Hypertension During PregnancyHypertension, 1997
- A Human Orphan Calcitonin Receptor-like StructureBiochemical and Biophysical Research Communications, 1995
- Calcitonin gene-related peptide in patients with and without early reperfusion after acute myocardial infarctionAmerican Heart Journal, 1992
- Circulating concentrations of calcitonin gene-related peptide (CGRP) in normal man determined with a new, highly sensitive radioimmunoassayPeptides, 1991
- The calcitonin‐like sequence of the β CGRP geneFEBS Letters, 1986